• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缺氧在阻塞性睡眠呼吸暂停与心血管死亡风险关系中的中介作用。

Mediation effect of hypoxia in the relationship between obstructive sleep apnea and cardiovascular death risk.

作者信息

Zhou Yan, Tan Xiqing, Lu Junjuan, Liu Chun

机构信息

Department of Pulmonary and Critical Care Medicine, Third Xiangya Hospital, Central South University, No.138 Tongzipo Road, Yuelu District, Changsha, 410013, Hunan, People's Republic of China.

出版信息

Sleep Breath. 2022 Dec;26(4):1729-1737. doi: 10.1007/s11325-022-02564-8. Epub 2022 Jan 10.

DOI:10.1007/s11325-022-02564-8
PMID:35013899
Abstract

PURPOSE

This study aimed to explore the role of hypoxia in the relationship between obstructive sleep apnea (OSA) and cardiovascular disease (CVD) death risk based on data from the Sleep Heart Health Study (SHHS).

METHODS

Multivariate logistic regression analysis was used to analyze the association between OSA, hypoxia, and CVD death risk. Causal mediation analysis was performed to assess the role of hypoxia. The severity of OSA was evaluated by the apnea-hypopnea index (AHI), and the hypoxia was quantified by the percentage of sleep time with less than 90% oxygen saturation (PCTST90).

RESULTS

Of these 5,145 participants, 989 had no OSA, 2,110 had mild OSA, and 2,046 had moderate-to-severe OSA. After adjusting all confounders, mild OSA [odds ratio (OR): 1.800; 95% confidence interval (CI), 1.192-2.802], moderate-to-severe OSA (OR: 1.745; 95%CI, 1.148-2.758), 0 < PCTST90 < 1 (OR: 1.668; 95%CI, 1.184-2.385), and PCTST90 ≥ 1 (OR: 1.649; 95%CI, 1.148-2.400) were associated with an increased death risk of CVD. Furthermore, participants with mild OSA (OR: 3.742; 95%CI, 3.183-4.398) and moderate-to-severe OSA (OR: 19.671; 95%CI, 16.303-23.734) had a higher risk of hypoxia than those without OSA. Causal mediation analysis indicated that the average direct effect (ADM) of moderate-to-severe OSA and average causal mediation effect (ACME) of hypoxia on CVD death risk were 0.024 (95%CI, 0.004-0.040) and 0.013 (95%CI, 0.005-0.020), respectively, and the average mediating effect ratio was 33.94%.

CONCLUSION

Hypoxia played a mediating role in the increased death risk of CVD caused by OSA, and the mediating effect of hypoxia did not account for a large proportion.

摘要

目的

本研究旨在基于睡眠心脏健康研究(SHHS)的数据,探讨缺氧在阻塞性睡眠呼吸暂停(OSA)与心血管疾病(CVD)死亡风险关系中的作用。

方法

采用多因素逻辑回归分析来分析OSA、缺氧与CVD死亡风险之间的关联。进行因果中介分析以评估缺氧的作用。OSA的严重程度通过呼吸暂停低通气指数(AHI)进行评估,缺氧通过氧饱和度低于90%的睡眠时间百分比(PCTST90)进行量化。

结果

在这5145名参与者中,989人无OSA,2110人有轻度OSA,2046人有中度至重度OSA。在调整所有混杂因素后,轻度OSA[比值比(OR):1.800;95%置信区间(CI),1.192 - 2.802]、中度至重度OSA(OR:1.745;95%CI,1.148 - 2.758)、0 < PCTST90 < 1(OR:1.668;95%CI,1.184 - 2.385)和PCTST90≥1(OR:1.649;95%CI,1.148 - 2.400)与CVD死亡风险增加相关。此外,轻度OSA(OR:3.742;95%CI,3.183 - 4.398)和中度至重度OSA(OR:19.671;95%CI,16.303 - 23.734)的参与者比无OSA的参与者有更高的缺氧风险。因果中介分析表明,中度至重度OSA对CVD死亡风险的平均直接效应(ADM)和缺氧的平均因果中介效应(ACME)分别为0.024(95%CI,0.004 - 0.040)和0.013(95%CI,0.005 - 0.020),平均中介效应比为33.94%。

结论

缺氧在OSA导致的CVD死亡风险增加中起中介作用,且缺氧的中介作用占比不大。

相似文献

1
Mediation effect of hypoxia in the relationship between obstructive sleep apnea and cardiovascular death risk.缺氧在阻塞性睡眠呼吸暂停与心血管死亡风险关系中的中介作用。
Sleep Breath. 2022 Dec;26(4):1729-1737. doi: 10.1007/s11325-022-02564-8. Epub 2022 Jan 10.
2
Association of Unrecognized Obstructive Sleep Apnea With Postoperative Cardiovascular Events in Patients Undergoing Major Noncardiac Surgery.未识别的阻塞性睡眠呼吸暂停与接受重大非心脏手术患者术后心血管事件的关联。
JAMA. 2019 May 14;321(18):1788-1798. doi: 10.1001/jama.2019.4783.
3
Association of obstructive sleep apnea and nocturnal hypoxemia with all-cancer incidence and mortality: a systematic review and meta-analysis.阻塞性睡眠呼吸暂停和夜间低氧血症与全癌发病率和死亡率的关系:系统评价和荟萃分析。
J Clin Sleep Med. 2022 May 1;18(5):1427-1440. doi: 10.5664/jcsm.9772.
4
Association of obstructive sleep apnea plus hypertension and prevalent cardiovascular diseases: A cross-sectional study.阻塞性睡眠呼吸暂停合并高血压与心血管疾病患病率的关联:一项横断面研究。
Medicine (Baltimore). 2016 Sep;95(39):e4691. doi: 10.1097/MD.0000000000004691.
5
NoSAS score predicts cardiovascular disease in patients with obstructive sleep apnea.NoSAS 评分可预测阻塞性睡眠呼吸暂停患者的心血管疾病。
Sleep Breath. 2024 Mar;28(1):87-93. doi: 10.1007/s11325-023-02856-7. Epub 2023 Jul 7.
6
Cardiovascular Outcomes and All-Cause Mortality in Patients with Obstructive Sleep Apnea and Chronic Obstructive Pulmonary Disease (Overlap Syndrome).阻塞性睡眠呼吸暂停和慢性阻塞性肺疾病(重叠综合征)患者的心血管结局和全因死亡率。
Ann Am Thorac Soc. 2019 Jan;16(1):71-81. doi: 10.1513/AnnalsATS.201802-136OC.
7
Implication of a novel measure of obstructive sleep apnea severity for cardiovascular morbidity.一种新的阻塞性睡眠呼吸暂停严重程度测量指标对心血管发病率的影响。
Sleep Med. 2023 Mar;103:204-210. doi: 10.1016/j.sleep.2023.02.001. Epub 2023 Feb 3.
8
Time Under 90% Oxygen Saturation and Systemic Hypertension in Patients with Obstructive Sleep Apnea Syndrome.阻塞性睡眠呼吸暂停综合征患者血氧饱和度低于90%的时间与系统性高血压
Nat Sci Sleep. 2022 Nov 30;14:2123-2132. doi: 10.2147/NSS.S388238. eCollection 2022.
9
Racial disparity in cardiovascular morbidity and mortality associated with obstructive sleep apnea: The sleep heart health study.阻塞性睡眠呼吸暂停相关心血管疾病发病率和死亡率的种族差异:睡眠心脏健康研究
Sleep Med. 2023 Jan;101:528-534. doi: 10.1016/j.sleep.2022.12.007. Epub 2022 Dec 8.
10
New index for analysis of polysomnography, 'integrated area of desaturation', is associated with high cardiovascular risk in patients with mild to moderate obstructive sleep apnea.新的睡眠呼吸暂停分析指标,“综合去饱和面积”,与轻中度阻塞性睡眠呼吸暂停患者的心血管高风险相关。
Respiration. 2009;78(3):278-84. doi: 10.1159/000202980. Epub 2009 Feb 16.

引用本文的文献

1
The impact of continuous positive airway pressure on cardiac mechanics: Findings from a meta-analysis of echocardiographic studies.持续气道正压通气对心脏力学的影响:超声心动图研究的荟萃分析结果。
J Clin Hypertens (Greenwich). 2022 Jul;24(7):795-803. doi: 10.1111/jch.14488. Epub 2022 Jun 13.

本文引用的文献

1
Obstructive sleep apnoea syndrome and cardiovascular risk with special reference to obesity and cognitive impairment.阻塞性睡眠呼吸暂停综合征与心血管风险,特别涉及肥胖和认知障碍。
Sleep Med. 2021 Jan;77:14. doi: 10.1016/j.sleep.2020.11.019. Epub 2020 Nov 23.
2
Low Prognostic Value of Novel Nocturnal Metrics in Patients With OSA and High Cardiovascular Event Risk: Post Hoc Analyses of the SAVE Study.新型夜间指标在伴有高心血管事件风险的 OSA 患者中预后价值较低:SAVE 研究的事后分析。
Chest. 2020 Dec;158(6):2621-2631. doi: 10.1016/j.chest.2020.06.072. Epub 2020 Jul 14.
3
The Sleep Apnea-Specific Hypoxic Burden Predicts Incident Heart Failure.
睡眠呼吸暂停特异性低氧负担预测心力衰竭事件。
Chest. 2020 Aug;158(2):739-750. doi: 10.1016/j.chest.2020.03.053. Epub 2020 Apr 13.
4
Diagnosis and Management of Obstructive Sleep Apnea: A Review.阻塞性睡眠呼吸暂停的诊断和治疗:综述。
JAMA. 2020 Apr 14;323(14):1389-1400. doi: 10.1001/jama.2020.3514.
5
Matrix metalloproteinases as possible biomarkers of obstructive sleep apnea severity - A systematic review.基质金属蛋白酶作为阻塞性睡眠呼吸暂停严重程度的可能生物标志物——系统评价。
Sleep Med Rev. 2019 Aug;46:9-16. doi: 10.1016/j.smrv.2019.03.010. Epub 2019 Mar 30.
6
Symptom Subtypes of Obstructive Sleep Apnea Predict Incidence of Cardiovascular Outcomes.阻塞性睡眠呼吸暂停的症状亚型预测心血管结局的发生率。
Am J Respir Crit Care Med. 2019 Aug 15;200(4):493-506. doi: 10.1164/rccm.201808-1509OC.
7
Composition of nocturnal hypoxaemic burden and its prognostic value for cardiovascular mortality in older community-dwelling men.夜间低氧血症负担的构成及其对老年社区男性心血管死亡率的预后价值。
Eur Heart J. 2020 Jan 21;41(4):533-541. doi: 10.1093/eurheartj/ehy838.
8
Solriamfetol for the Treatment of Excessive Sleepiness in OSA: A Placebo-Controlled Randomized Withdrawal Study.索里昂®(Solriamfetol)治疗阻塞性睡眠呼吸暂停(OSA)患者嗜睡:一项安慰剂对照的随机撤药研究。
Chest. 2019 Feb;155(2):364-374. doi: 10.1016/j.chest.2018.11.005. Epub 2018 Nov 22.
9
Sleep Apnea and Cardiovascular Disease: An Enigmatic Risk Factor.睡眠呼吸暂停与心血管疾病:一个神秘的危险因素。
Circ Res. 2018 Jun 8;122(12):1741-1764. doi: 10.1161/CIRCRESAHA.118.310783.
10
Sleep Apnea and Cardiovascular Disease: Lessons From Recent Trials and Need for Team Science.睡眠呼吸暂停与心血管疾病:近期试验的经验教训及团队科学的必要性。
Circulation. 2017 Nov 7;136(19):1840-1850. doi: 10.1161/CIRCULATIONAHA.117.029400.